All times are listed in CET (Central European Time)

Browsing Over 190 Presentations

Sort By
Mesothelioma: Will I-O shape the future? Educational session

Molecular risk factors and predictive biomarkers

Lecture Time
10:00 - 10:15
Speakers
  • G. Zalcman (Paris, France)
Session Name
Mesothelioma: Will I-O shape the future?
Room
Channel 3
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • G. Zalcman (Paris, France)
Mesothelioma: Will I-O shape the future? Educational session

What is the standard of care in front-line and beyond?

Lecture Time
10:15 - 10:30
Speakers
  • A. Tsao (Houston, TX, United States of America)
Session Name
Mesothelioma: Will I-O shape the future?
Room
Channel 3
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • A. Tsao (Houston, TX, United States of America)
Mesothelioma: Will I-O shape the future? Educational session

Indication for lung-sparing radiotherapy

Lecture Time
10:30 - 10:45
Speakers
  • A. Rimner (New York, NY, United States of America)
Session Name
Mesothelioma: Will I-O shape the future?
Room
Channel 3
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • A. Rimner (New York, NY, United States of America)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:31 - 11:37
Speakers
  • L. Paz-Ares (Madrid, Spain)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • L. Paz-Ares (Madrid, Spain)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Presentation of case: Monotherapy or chemoimmunotherapy in PD-L1>50%?

Lecture Time
11:15 - 11:20
Speakers
  • L. Landi (Ravenna, Italy)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • L. Landi (Ravenna, Italy)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Options in patients with brain metastases

Lecture Time
11:20 - 11:35
Speakers
  • O. Gautschi (Luzern, Switzerland)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • O. Gautschi (Luzern, Switzerland)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Role of chemo-free combinations

Lecture Time
11:35 - 11:50
Speakers
  • S. Ramalingam (Atlanta, GA, United States of America)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • S. Ramalingam (Atlanta, GA, United States of America)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Role of chemo-IO combinations

Lecture Time
11:50 - 12:05
Speakers
  • F. Cappuzzo (Rome, NY, Italy)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • F. Cappuzzo (Rome, NY, Italy)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Role of single agent immunotherapy

Lecture Time
12:05 - 12:20
Speakers
  • M. Garcia Campelo (A Coruña, Spain)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • M. Garcia Campelo (A Coruña, Spain)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Welcome and Young Oncologists perspective

Lecture Time
11:15 - 11:25
Speakers
  • J. Lim (Manchester, United Kingdom)
  • A. Berghoff (Vienna, Austria)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • J. Lim (Manchester, United Kingdom)
  • A. Berghoff (Vienna, Austria)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Q&A and live discussion

Lecture Time
12:20 - 12:35
Speakers
  • A. Speakers (, Switzerland)
Session Name
Optimal management of patients with PDL1-high advanced NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • A. Speakers (, Switzerland)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:43 - 11:49
Speakers
  • F. Blackhall (Manchester, United Kingdom)
Session Name
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start?
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • F. Blackhall (Manchester, United Kingdom)